SCHEMBL5794142

SCHEMBL5794142

Cc1cc(N(CC(C)(C)C)NC(=O)OC(C)(C)C)nc(Cl)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
STK17B O94768 1/20 0.34
STK17A Q9UEE5 1/20 0.34
GPR4 P46093 2/20 0.33
AKT1 P31749 2/20 0.33
ALDH1A1 P00352 1/20 0.33
ATR Q13535 1/20 0.32
LCK P06239 3/20 0.32
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
NPC1 O15118 1/20 0.32
GAA P10253 1/20 0.32
RAB9A P51151 1/20 0.32
AAK1 Q2M2I8 3/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5804885 0.86 MEN1 (0.38) MEN1KMT2ASTK17BSTK17ACA12
SCHEMBL5791032 0.82 GPR119 (0.40) GPR4AKT1ALDH1A1ACACBACACA
SCHEMBL8125809 0.81 ATR (0.42) MEN1KMT2ASTK17BSTK17AGPR4
SCHEMBL5306751 0.76 STK17B (0.37) STK17BSTK17AAKT1CA12CA1
SCHEMBL5823667 0.75 STK17B (0.43) STK17BSTK17AAKT1ATRAAK1
SCHEMBL5305779 0.74 AAK1 (0.36) STK17BSTK17AATRCA12CA1
SCHEMBL5306339 0.73 STK17B (0.49) MEN1KMT2ASTK17BSTK17AAKT1
SCHEMBL3409879 0.72 MEN1 (0.47) MEN1KMT2ASTK17BSTK17AALDH1A1
SCHEMBL8244837 0.71 STK17B (0.42) MEN1KMT2ASTK17BSTK17AAKT1
SCHEMBL3176616 0.71 STK17B (0.42) MEN1KMT2ASTK17BSTK17AAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006027211-A1 2,4-SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2006-03-16 WO disclosed